10-K Decoder · All companies

Protagonist Therapeutics, Inc.

PTGX · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$46.0M$434M−89.4%
Operating income−$158M$253M
Net income−$130M$275M

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 6, 2026

$Q3 2026Year earlierChange
Revenue$274M$4.70M+5,738%
Operating income$218M−$46.4M
Net income$220M−$39.3M

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Protagonist's revenue in FY2025?
$46.0M in FY2025 (Fiscal year ended Dec 31, 2025), −89.4% vs $434M a year earlier, per its 10-K filed Feb 2026.
Was Protagonist profitable in FY2025?
No: net income was −$130M and operating income −$158M in FY2025.
What was Protagonist's revenue in Q3 2026?
$274M (+5,738% vs a year earlier), per its Form 10-Q filed Nov 6, 2026.